Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors

Conditions: Advanced Solid Tumor; HER2-negative Breast Cancer; Metastatic Castration-resistant Prostate Cancer (mCRPC); Pancreatic Cancer; Platinum-resistant Ovarian Cancer (PROC) Interventions: Drug: NUV-1511 Sponsors: Nuvation Bio Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials